Document Detail


Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
MedLine Citation:
PMID:  22535689     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Alpha-fetoprotein is a tumour marker that has been used for surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. The prognostic capability of this marker in patients with hepatocellular carcinoma has not been clearly defined. In this study our aim was to evaluate the prognostic usefulness of serum alpha-fetoprotein in patients with well-compensated cirrhosis, optimal performance status, and small hepatocellular carcinoma identified during periodic surveillance ultrasound who were treated with curative intent. Among the 3,027 patients included in the Italian Liver Cancer study group patients we selected 205 Child-Pugh class A and Eastern Cooperative Group Performance Status 0 cirrhotic patients with a single hepatocellular carcinoma ≤3 cm of diameter diagnosed during surveillance who were treated with curative intent (hepatic resection, liver transplantation, percutaneous ethanol injection, radiofrequency thermal ablation). Patients were sub-divided according to alpha-fetoprotein serum levels (i.e., normal ≤20 ng/mL; altered 21-200 ng/mL; diagnostic >200 ng/mL). Patients survival, as assessed by the Kaplan-Meier method, was not significantly different among the three alpha-fetoprotein classes (P=0.493). The same result was obtained in the subgroup of patients with a single hepatocellular carcinoma ≤2cm (P=0.714). An alpha-fetoprotein serum level of 100 ng/mL identified by receiver operating characteristic curve had inadequate accuracy (area under the curve=0.536, 95% confidence interval=0.465-0.606) to discriminate between survivors and deceased patients. CONCLUSIONS: Alpha-fetoprotein serum levels have no prognostic meaning in well-compensated cirrhotic patients with single, small hepatocellular carcinoma treated with curative intent. (HEPATOLOGY 2012.).
Authors:
Edoardo G Giannini; Simona Marenco; Giacomo Borgonovo; Vincenzo Savarino; Fabio Farinati; Paolo Del Poggio; Gian Ludovico Rapaccini; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani;
Related Documents :
18551749 - Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification bas...
22889569 - Recommendations for the use of radiotherapy in nodal lymphoma.
22442909 - Elective neck dissection in papillary thyroid carcinoma patients.
22731929 - Outpatient intravenous interleukin-2 with famotidine has activity in metastatic melanoma.
22830869 - Poster - thur eve - 53: analysis of the distribution of dose delivery during respirator...
22320219 - Response and survival of patients with chronic graft-versus-host disease treated by ext...
3681379 - Effects of socioeconomic and clinical factors on survival in multiple myeloma.
1395979 - The fate of patients following polypectomy alone for polyps containing invasive carcinoma.
14566259 - Thymoma: a clinicopathologic study based on the new world health organization classific...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-26
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  -     ISSN:  1527-3350     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 American Association for the Study of Liver Diseases.
Affiliation:
Dipartimento di Medicina Interna, Unità di Gastroenterologia, Università di Genova, Italy. egiannini@unige.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Potential Repurposing of Known Drugs as Potent Bacterial ?-Glucuronidase Inhibitors.
Next Document:  Chemoprotective effects of carnosine against genotoxicity induced by cyclophosphamide in mice bone m...